Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_assertion type Assertion NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_head.
- NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_assertion description "[A new era in MPN biology began in 2005 with the discovery of a somatic point mutation in JAK2 tyrosine kinase (JAK2V617F), which was identified in a significant proportion of patients with PV, ET and PMF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_provenance.
- NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_assertion evidence source_evidence_literature NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_provenance.
- NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_assertion SIO_000772 18754026 NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_provenance.
- NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_assertion wasDerivedFrom befree-20140225 NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_provenance.
- NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_assertion wasGeneratedBy ECO_0000203 NP166459.RAwVqrQNX_5Q5zmo_H6sy9pw_v01G8UybdZO5S8vS9BYg130_provenance.